RACHAEL BENSON: Open Payments
NPI 1407585508 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,788 in 159 payments from 31 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $3,788
Food & beverage: $3,614Education: $174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $533 |
| Eisai Inc. | 17 | $530 |
| Novartis Pharmaceuticals Corporation | 19 | $306 |
| Biogen, Inc. | 15 | $296 |
| Neurocrine BioSciences, Inc. | 8 | $185 |
| Lilly USA, LLC | 8 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $172 |
| Mallinckrodt Hospital Products Inc. | 3 | $159 |
| Lundbeck LLC | 14 | $145 |
| Janssen Biotech, Inc. | 4 | $143 |
Products named: Leqembi, KESIMPTA, QULIPTA, TYSABRI, INGREZZA, HYQVIA, ACTHAR, UPLIZNA.
Industry payments across IL — which companies pay providers there.
